With the AUA’s newly released clinical guidelines on diagnosing, counseling, and treating patients with GSM, we knew we had to invite Dr. Gina Northington, a panel member directly involved in developing these guidelines, onto the podcast for a special pop-up episode!

In this roundtable conversation, Dr. Northington joins Drs. Jasmine Tibon, Christine Vaccaro, and Jocelyn Fitzgerald to discuss the guideline development process, their publication, and the broader impact these recommendations will have on clinical care. They also explore how this work contributed to the U.S. Department of Health and Human Services’ decision to remove the black box warning from hormone-replacement therapies.